The Latest Breaking News from Gilead

'The White Lotus' finale, 'Dying for Sex' and 'Black Bag' lead my weekend watch list

We've watched June run in and out of Gilead and now we're running with her

Fans can expect the final instalment to deliver the ultimate showdown between the rebels, led by Elizabeth Moss’s June, and Gilead

Praise be

After eight years of fascist dystopia, June Osborne finally gets to rest.

JPMorgan's upgrade on Gilead sparks bullish sentiment for the healthcare sector—here's why stocks like Pfizer and Hims & Hers are promising opportunities.

Trump’s proposed tariffs on pharmaceutical imports from countries like Ireland and India have sparked concerns for companies like Amgen and Gilead Sciences.

The UNAIDS director also warned that US funding cuts could be dire for global efforts to curb HIV.

The world risks returning to the worst days of the global AIDS pandemic following the sudden halt to US foreign aid funding, the UN's top AIDS official said Monday, warning millions would die.

The head of the U.N. AIDS agency says the sudden loss of American money has been “devastating” for efforts to stop HIV and will cost many lives of the world’s most vulnerable people

Summary Gilead Sciences (GILD) shows strong technical buy signals, with a 19.60% gain since Trend Seeker's buy signal on 1/27 and a 50.31% gain in the last year. The company offers a diverse portfolio of medicines for HIV, COVID-19, liver diseases, oncology, and more, with significant collaborations enhancing its pipeline....